Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2011
09/08/2011US20110217703 P2/p2a/p2b gene sequences as diagnostic targets for the identification of fungal and yeast species
09/08/2011US20110217695 BETAG1-IgG INTRON FOR ENHANCED ANTI-IGF1R EXPRESSON
09/08/2011US20110217414 Polypeptides having tyrosinase activity and polynucleotides encoding same
09/08/2011US20110217367 Means for inhibiting the expression of orc-1
09/08/2011US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof
09/08/2011US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof
09/08/2011US20110217334 Hypoallergenic molecules
09/08/2011US20110217326 Method for diagnosing and/or treating tumor
09/08/2011US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen
09/08/2011US20110217318 Anti-platelet membrane glycoprotein vi monoclonal antibody
09/08/2011US20110217316 GBS Toxin Receptor Compositions and Methods of Use
09/08/2011US20110217306 C-terminal exon 5.4 of runx1/aml1
09/08/2011US20110217305 Anti-her2 antibodies and compositions
09/08/2011US20110217304 Monoclonal antibodies directed to cd52
09/08/2011US20110217302 TCR Complex Immunotherapeutics
09/08/2011US20110217298 Monoclonal antibodies directed to cd20
09/08/2011US20110217291 Soluble hybrid fct receptors and related methods
09/08/2011US20110217290 Treatment and/or prevention of peanut induced anaphylaxis
09/08/2011US20110217284 Factor IX Variants with Clotting Activity in Absence of Their Cofactor and Their Use for Treating Bleeding Disorders
09/08/2011US20110217267 Gene therapy vectors and cytosine deaminases
09/08/2011US20110217266 Genomic sequence of avian paramyxovirus type 2 and uses thereof
09/08/2011US20110217241 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
09/08/2011US20110217237 Therapeutic dll4 binding proteins
09/08/2011US20110217235 Alpha 1-3 n-galactosyltransferase with altered donor specificities
09/08/2011DE102010010052A1 Signalgebende Bindemoleküle, Vorrichtungen und Verfahren zu deren Verwendung Signaling binding molecules, devices, and methods of use thereof
09/07/2011EP2363821A2 Method and device for optimising a nucleotide sequence for expressing a protein
09/07/2011EP2363505A2 Diagnosis of melanoma by nucleic acid analysis
09/07/2011EP2363503A1 Modulation of HIF1A and HIF2A expression
09/07/2011EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
09/07/2011EP2363480A2 Modulation of glucocorticoid receptor expression
09/07/2011EP2363404A2 PSMA antibodies
09/07/2011EP2363403A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
09/07/2011EP2363141A1 Compsition comprising two oligonucleotides linked directly at their 3'ends wherein at leat one oligonucleotide has an accessible 5'end and the compound further comprising IL-2 used for synergistically stimulating an immune response in a patient.
09/07/2011EP2362907A2 Nucleic acid extraction on curved glass surfaces
09/07/2011EP2362877A2 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same
09/07/2011EP0871646B1 Dna sequencing by parallel oligonucleotide extensions
09/07/2011CN102177233A Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
09/07/2011CN102177178A Anti-IL-12/IL-23 antibodies
09/07/2011CN102174538A Detection of mutations in a gene associated with resistance to viral infection, oas1
09/07/2011CN102174490A Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
09/07/2011CN102174092A ABA (abscisic acid) and salt related protein STS1 (steroid sulfatase 1) and encoding genes and application thereof
09/07/2011CN101612541B Preparation of polyacrylic acid coated ferroferric oxide magnetic nano-particles and application thereof
09/07/2011CN101220360B SiRNA sequence restraining caspase-3 gene expression
09/07/2011CN101037691B CENP-E combined protein and encoding gene and application
09/06/2011US8014955 Method of identifying unique target sequence
09/06/2011US8013216 Using vector transformation to generate transgenic brassica with enhanced Delta 6-C18-fatty acid content; plant oil comprising improved nutraceutical content
09/06/2011US8013212 Site-specific recombination in eukaryotes and constructs useful therefor
09/06/2011US8013147 Heterocyclic compounds and their use in the detection of nucleic acids
09/06/2011US8013146 RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
09/06/2011US8013145 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy
09/06/2011US8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof
09/06/2011US8013143 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
09/06/2011US8013142 Compositions for use in identification of bacteria
09/06/2011US8013141 Promoter with high expression strength and over-expression in various tissues of plant, as well as application thereof
09/06/2011US8013140 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
09/06/2011US8013139 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
09/06/2011US8013136 Oligonucleotides comprising a non-phosphate backbone linkage
09/06/2011US8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
09/06/2011US8013134 Kit for proximity probing with multivalent proximity probes
09/06/2011US8013133 Genetic modification of targeted regions of the cardiac conduction system
09/06/2011US8012948 Fas/FasL or other death receptor targeted methods and compositions for killing tumor cells
09/06/2011US8012947 Methods and compositions for promoting wound healing
09/06/2011US8012931 Modified FGF-21 polypeptides and their uses
09/06/2011US8012756 Charge perturbation detection system for DNA and other molecules
09/06/2011US8012748 Peripheral nervous system specific sodium channel nucleic acids
09/06/2011US8012734 Cellulase variants with reduced inhibition by glucose
09/06/2011US8012732 Fungal lypolytic and amylase enzyme composition and methods using the same
09/06/2011US8012731 Phosphodiesterase and gene thereof
09/06/2011US8012730 Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin
09/06/2011US8012729 Mutant glucose dehydrogenase
09/06/2011US8012726 Method of making bioethanol by using glucose isomerase mutants
09/06/2011US8012725 Method for the production of optically-active alcohols
09/06/2011US8012690 Enriching for sequestered populations of amplified nucleic acid molecules; immobilizing preferential nucleotide sequences onto beads, replicating sequences, recovering propagated nucleotide sequences
09/06/2011US8012689 Elite event A2407-12 and methods and kits for identifying such event in biological samples
09/06/2011US8012687 Isolated genomic polynucleotide fragments from chromosome 19 that encode human resistin and the human syntaxin binding protein 2
09/06/2011US8012686 Risk assessment for adverse drug reactions
09/06/2011US8012685 Detection of analytes and nucleic acids
09/06/2011US8012684 Mutated AQP, method for detecting cancer using the same, DNA chip having oligonucleotides of said mutated AQP sequence
09/06/2011US8012681 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
09/06/2011US8012680 Microchip, nucleic acid extracting kit, and nucleic acid extracting method
09/06/2011US8012482 Humanized anti-TGF-beta antibodies
09/06/2011US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders
09/01/2011WO2011106689A1 Modulation of smad3 expression
09/01/2011WO2011106583A1 Polytag probes
09/01/2011WO2011106456A2 Artificial mycolic acid membranes
09/01/2011WO2011106314A2 Method of making nucleic acid libraries
09/01/2011WO2011105654A1 Y-probe and variation thereof, and dna microarray, kit, and gene analysis method using the y-probe and the variation thereof
09/01/2011WO2011061373A8 Quantification of bovine polyomavirus (bpyv) for tracing bovine contamination in the environment
09/01/2011US20110214209 Modified bacillus thuringiensis cry12 proteins for nematode control
09/01/2011US20110214208 Modified Bacillus Thuringiensis Cry5 Proteins For Nematode Control
09/01/2011US20110214206 Nucleic acid molecules and other molecules associated with plants
09/01/2011US20110214204 Polynucleotides encoding proteins involved in plant metabolism
09/01/2011US20110214203 Sugar and lipid metabolism regulators in plants ii
09/01/2011US20110214202 CVYV-Resistant Plants of the Species Cucumis Melo
09/01/2011US20110214201 Method for Producing Haploid, Doubled Haploid and/or Dihaploid Plants by Gynogenesis
09/01/2011US20110214200 Yield traits for maize
09/01/2011US20110214192 Photoconvertible fluorescent proteins
09/01/2011US20110213337 Methods for the early diagnosis of ovarian cancer
09/01/2011US20110213136 Antisense modulation of stearoyl-coa desaturase expression
09/01/2011US20110213135 Cytotoxic Nucleotides for Targeted Therapeutics